Effect of Advanced Glycation End Products on the Progression of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Effect of Advanced Glycation End Products on the Progression of Alzheimer’s Disease

Published:2019-10-29 Issue:1 Volume:72 Page:191-197
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Chou Ping-Song¹²,Wu Meng-Ni¹²,Yang Chen-Cheng³⁴,Shen Cheng-Ting⁵⁶,Yang Yuan-Han¹²⁷⁸

Affiliation:

1. Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

2. Department of and Master’s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

3. Department of Environmental and Occupational Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

4. Department of Environmental and Occupational Medicine, and Health Management Center, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

5. Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

6. Department of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

7. Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan

8. Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference31 articles.

1. Epidemiology of dementias and Alzheimer’s disease;Sosa-Ortiz;Arch Med Res,2012

2. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease;Zhang;Diabetes Res Clin Pract,2017

3. Alzheimer’s disease and diabetes: An integrative view of the role of mitochondria, oxidative stress, and insulin;Moreira;J Alzheimers Dis,2012

4. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease;De Felice;Diabetes,2014

5. Diabetes and cognitive dysfunction;McCrimmon;Lancet,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inhibitory effects of endophytic metabolites on glycated proteins under non-communicable disease conditions: A review;International Journal of Biological Macromolecules;2024-06

2. Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial);Frontiers in Endocrinology;2024-05-30

3. Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam);PLOS ONE;2024-05-29

4. Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam);2024-04-19

5. The ketogenic diet as a treatment paradigm for neurological disease;Reference Module in Neuroscience and Biobehavioral Psychology;2024